Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy
Enterococci are implicated in less than 2.3% of prosthetic joint infections. These infections can be difficult to treat and therapeutic failures are not uncommon. In these situations, daptomycin is a safe and effective alternative. We present a clinical case with a successful response to the prolong...
Main Authors: | José Ramón Yuste, Milena Quesada, Pablo Díaz-Rada, José Luis Del Pozo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-10-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S120197121401563X |
Similar Items
-
Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States
by: Amy S. Gargis, et al.
Published: (2022-02-01) -
Salphage: Salvage bacteriophage therapy for a chronic Enterococcus faecalis prosthetic joint infection
by: James B. Doub, et al.
Published: (2023-01-01) -
Successful treatment of a prosthetic hip infection due to Enterococcus faecalis with sequential dosing of oritavancin and prosthesis preservation without prosthetic joint surgical manipulation
by: Jullian P. Nguyen, et al.
Published: (2020-01-01) -
The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
by: Masoud Dadashi, et al.
Published: (2021-09-01) -
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
by: Maddalena Peghin, et al.
Published: (2019-08-01)